If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrp Advisory Group Regulatory News (FRP)

Share Price Information for Frp Advisory Group (FRP)

Share Price is delayed by 15 minutes
Get Live Data
113.00    -2.00 (-1.74%)
Bid:
112.00
Ask:
114.00
Spread: 2.00 (1.786%)
Market Cap: £279.21m
FRP Live PriceLast checked at - London Stock Exchange

Intraday Frp Advisory Group Share Chart

Payment of deferred consideration

8 Feb 2017 07:00

RNS Number : 2773W
Fairpoint Group PLC
08 February 2017
 

8 February 2017

 

Fairpoint Group plc

 

Payment of deferred consideration for the acquisition of Colemans-CTTS LLP

 

On 17 August 2015 Fairpoint Group plc ("Fairpoint" or "the Group") completed the acquisition of the trade and assets of Colemans-CTTS LLP, CT Support Services Limited and the entire ordinary share capital of Holiday TravelWatch Limited (together referred to as "Colemans").

 

The terms of the acquisition ("the Terms") made provision for deferred and contingent consideration of up to £7.0 million payable subject to the achievement of certain financial and integration performance criteria ("the Earn-out Consideration"). The Earn-out Consideration comprised two payments of up to £3.5 million each, based upon the performance for the 11 month period ending 30 June 2016 ("the First Earn-out Period") and the 12 month period ending 30 June 2017 ("the Second Earn-out Period"), to be satisfied 50% in cash and 50% through the issue of new ordinary shares ("Earn-out Shares"). The Earn-out Shares were to be issued at an effective fixed price of 132p per ordinary share.

 

The Group has entered into a deed of variation to the Terms with the vendors of Colemans ("the Revised Terms"), which varied the financial and integration targets, the mix of cash and share consideration payable, and adjusted the effective fixed issue price per Earn-out Share to 100p. Based on the Revised Terms, the maximum consideration payable in relation to the Second Earn-out Period (subject to the achievement of revised performance criteria) is in aggregate £1.5 million, to be satisfied in cash of up to £1.0 million and through the issue of 500,000 new ordinary shares. 

 

The deferred consideration payable in respect of the First Earn-out Period, based on performance from 17 August 2015 to 30 June 2016, is £1.6 million in cash and the issue of 1,540,000 new ordinary shares at the revised effective price of 100p per ordinary share. The vendors are restricted from dealing in the shares allotted at the end of the First Earn-out Period until 30 June 2017 and in the shares allotted at the end of the Second Earn-Out Period until 30 June 2018.

 

Application has been made for the 1,540,000 Earn-out Shares relating to the First Earn-out Period to be admitted to AIM on 13 February 2017. Upon admission of the Earn-out Shares to AIM, the enlarged issued share capital of the Group, excluding 1,194,167 ordinary shares held in treasury, will be 48,249,518 ordinary shares. This is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Group under the FCA's Disclosure and Transparency Rules.

 

 

Enquiries please contact:

 

Fairpoint Group Plc  

Dave Broadbent, Chief Financial Officer 020 3128 8794

Shore Capital (Nomad and Broker)

Mark Percy 020 7408 4090

Edward Mansfield

 

Panmure Gordon & Co (Broker)

Dominic Morley 020 7866 2500

 

MHP Communications

Reg Hoare 020 3128 8100

Katie Hunt fairpoint@mhpc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCOKODNOBKDABK
Date   Source Headline
1st Jul 20267:00 amRNSNotice of Results
21st May 20264:39 pmRNSHolding(s) in Company
21st May 20264:22 pmRNSPurchase of Ordinary Shares by EBT
15th May 20267:00 amRNSFull Year Trading Update
27th Apr 20267:00 amRNSShareholder Lock-Ins
20th Mar 202610:43 amRNSHolding(s) in Company
17th Mar 20261:49 pmRNSHolding(s) in Company
27th Feb 20266:15 pmRNSHolding(s) in Company
27th Feb 20266:08 pmRNSHolding(s) in Company
23rd Feb 20267:00 amRNSQ3 Dividend Declaration
13th Jan 20262:51 pmRNSChange of Auditor
9th Jan 20263:40 pmRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSGrant of Options and Director Dealing
19th Dec 20257:00 amRNSGrant of Options and Director Dealing
18th Dec 20257:00 amRNSHalf-year Report
1st Dec 20256:08 pmRNSTotal Voting Rights
21st Nov 20257:00 amRNSTrading Statement
14th Nov 20257:00 amRNSAcquisition of Arc & Co Structured Finance Limited
23rd Sep 20253:43 pmRNSResult of AGM
23rd Sep 20257:00 amRNSAGM Statement and Q1 Dividend Declaration
3rd Sep 20257:00 amRNSDirector/PDMR Shareholding
26th Aug 20255:32 pmRNSNotice of Annual General Meeting
19th Aug 202510:04 amRNSAnnual Financial Report
19th Aug 20258:45 amRNSGrant of Options and Director Dealing
23rd Jul 20257:00 amRNSFull Year Results
30th May 20257:00 amRNSTotal Voting Rights
12th May 20257:00 amRNSAcquisition of One Advisory Group
8th May 20257:00 amRNSFull Year Trading Update
1st May 20253:35 pmRNSAIM Rule 17 Update
11th Mar 20251:55 pmRNSDirector/PDMR Shareholding
17th Feb 20257:00 amRNSQ3 Trading Update and Dividend Declaration
14th Jan 20257:00 amRNSAppointment of Joint Corporate Broker
10th Jan 20255:00 pmRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSHalf-year Report
20th Nov 20247:00 amRNSHalf Year Trading Update
31st Oct 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSAcquisition of Globalview Advisors Limited
15th Oct 20242:42 pmRNSPDMR Dealing
30th Sep 202410:22 amRNSTotal Voting Rights
26th Sep 202410:49 amRNSResult of AGM
26th Sep 20247:00 amRNSAGM Statement and Q1 Dividend Declaration
23rd Sep 20247:00 amRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSAcquisition of WilliamsAli Corporate Finance
23rd Aug 20247:00 amRNSNotice of AGM
16th Aug 202411:39 amRNSAnnual Report & Accounts
1st Aug 20243:35 pmRNSDirector/PDMR Shareholding
31st Jul 202410:50 amRNSTotal Voting Rights
24th Jul 20242:40 pmRNSReplacement - Full Year Results
24th Jul 20247:00 amRNSFull Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.